Better Cannabis Stock: Aurora (TSX:ACB) or Green Organic (TSX:TGOD)?

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) or The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) are two very different cannabis stocks, so which deserves your cash?

| More on:
edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

One is top tier; one is starting expansion.

One is inexpensive; the other is ridiculously cheap.

But are either Aurora Cannabis (TSX:ACB)(NYSE:ACB) or Green Organic Dutchman Holdings (TSX:TGOD) worth your investment?

Aurora

Aurora has long been touted as one of the top three cannabis stocks out there, but with that title has come endless scrutiny. The company’s recent announcement that it would not be partnering outside the cannabis industry if it meant giving up its independence sent the stock even lower to where it is at the time of writing at about $10.75 per share.

The decision came from strategic advisor Nelson Peltz, who believes having multiple partners in several industries could be a better option. This could mean greater returns over the long run rather than an influx of sudden cash.

But what investors don’t like is this likely means a continuation of using shareholder funds to pay for these partnerships, like the company’s acquisitions. It means being even more patient while the company continues to expand, grow, and hopefully create a base that will explode when everything is up and running.

Analysts put the stock’s movement at between $10 and $15 over the next 12 months, so if you’re looking for a quick sell, I wouldn’t hold your breath. But for those already with Aurora in hand, just hold on and ignore this stock for the next while.

Green Organic Dutchman

This company is finally coming out strong, with news that sent shares up last week when the cannabis company secured a supply agreement with the province of Ontario. This was after further news that the company was expanding into the U.S. market by co-founding and becoming a strategic partner with Califormulations LLC to create hemp-based CBD beverages.

While other cannabis companies have already done things like this, Green Organic is finally making the moves that could send its stock up — not to potentially be in a top-tier position, mind you, but perhaps in a spot where it could be a takeover opportunity. After all, peak production of 220,000 kilograms per year at the end of 2020 isn’t anything to sneeze at and would make a handsome addition to some of the bigger cannabis companies.

So, whereas you’ll have to wait and see with Aurora, there could be some major moves with Green Organic over the next while. Depending on how your portfolio is positioned and what you’re looking for, this could be an opportunity to make some quick cash. Especially since the stock is down after its latest announcements.

Foolish takeaway

Like I’ve said, it really depends for what you’re looking for as an investor when it comes to these two cannabis stocks. If you’re looking for the excitement of the early days, I would choose Green Organic. This stock is bound to make some more moves in the next year that could send the stock from its price at $3.84 at the time of writing to as high as $10 per share in the next 12 months! That’s an increase of 160%!

But if you’re looking for a long term, slightly more stable investment, I would go with Aurora. While this company isn’t as exciting as it once was, it’s playing a game of chess right now, setting up its pieces for an explosion in profit in the future. When that future is, however, I can’t be certain.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Aurora Cannabis.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »